SAM
NBIX icon

Securian Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Securian Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Hold
7,398
– – 0.05% 287
2026
Q1 		$975K Buy
7,398
+196
+3% +$26K 0.04% 333
2025
Q4 		$1.02M Sell
7,202
-226
-3% -$32.7K 0.04% 314
2025
Q3 		$1.04M Sell
7,428
-126
-2% -$17.1K 0.03% 428
2025
Q2 		$949K Hold
7,554
– – 0.03% 445
2025
Q1 		$835K Sell
7,554
-100
-1% -$12.7K 0.03% 475
2024
Q4 		$1.04M Sell
7,654
-198
-3% -$24.5K 0.03% 417
2024
Q3 		$905K Sell
7,852
-174
-2% -$23.9K 0.03% 475
2024
Q2 		$1.1M Sell
8,026
-123
-2% -$16.9K 0.03% 385
2024
Q1 		$1.12M Sell
8,149
-122
-1% -$16.7K 0.03% 397
2023
Q4 		$1.09M Hold
8,271
– – 0.03% 411
2023
Q3 		$930K Sell
8,271
-421
-5% -$44.3K 0.03% 450
2023
Q2 		$820K Sell
8,692
-142
-2% -$13.9K 0.02% 524
2023
Q1 		$894K Hold
8,834
– – 0.02% 497
2022
Q4 		$1.06M Buy
8,834
+121
+1% +$14.2K 0.03% 452
2022
Q3 		$925K Hold
8,713
– – 0.03% 464
2022
Q2 		$849K Buy
8,713
+225
+3% +$20.8K 0.02% 546
2022
Q1 		$796K Hold
8,488
– – 0.02% 611
2021
Q4 		$723K Hold
8,488
– – 0.01% 656
2021
Q3 		$814K Sell
8,488
-201
-2% -$19K 0.02% 602
2021
Q2 		$846K Sell
8,689
-171
-2% -$16.4K 0.02% 613
2021
Q1 		$862K Buy
+8,860
New +$929K 0.02% 601

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Securian Asset Management's NBIX Position: Q2 2026 in Review

Securian Asset Management held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 7,398 shares worth $1.26M. The position accounts for 0.05% of the portfolio, ranked #287.

Securian Asset Management first reported a position in NBIX in Q1 2021 and has held it in 22 quarters since. 154 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Securian Asset Management held 7,398 shares of Neurocrine Biosciences worth $1.26M as of Q2 2026.
  • Securian Asset Management left its Neurocrine Biosciences share count unchanged in Q2 2026.
  • Neurocrine Biosciences made up 0.05% of Securian Asset Management's portfolio in Q2 2026, its #287 holding.
  • Securian Asset Management first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 22 quarters since.
  • 154 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.